Table 3 Prevalence of altered values of different scales related to cardiovascular risk in elderly people by sex

Waist to height ratio > 0.50

28.4

51.3

< 0.0001

Body mass index obesity

23.3

29.4

< 0.0001

CUN BAE obesity

85.8

85.4

0.687

ECORE-BF obesity

81.5

84.2

< 0.0001

Relative fat mass obesity

58.1

43.8

< 0.0001

Palafolls formula obesity

89.1

94.6

< 0.0001

Deuremberg formula obesity

93.2

99.5

< 0.0001

Hypertension

42.7

57.9

< 0.0001

Total cholesterol ≥ 200 mg/dl

68.6

53.7

< 0.0001

LDL-c ≥ 130 mg/dl

62.4

51.1

< 0.0001

Triglycerides ≥ 150 mg/dl

16.7

32.7

< 0.0001

Glycemia 100–125 mg/dl

25.7

35.7

< 0.0001

Glycemia ≥ 126 mg/dl

5.6

13.2

< 0.0001

Metabolic syndrome NCEP ATPIII criteria

30.8

42.7

< 0.0001

Metabolic syndrome IDF criteria

21.2

20.7

0.455

Metabolic syndrome JIS criteria

34.4

58.6

< 0.0001

Atherogenic dyslipidemia

10.6

15.5

< 0.0001

Lipid triad

3.1

4.4

< 0.0001

Hipertriglyceridemic waist

2.6

11.0

< 0.0001

Atherogenic index total cholesterol/HDL-c moderate-high

31.6

33.5

< 0.0001

Atherogenic index triglycerides/HDL-c high

16.2

42.5

< 0.0001

Atherogenic index LDL-c/HDL-c high

34.0

46.2

< 0.0001

SCORE scale high

15.7

62.4

< 0.0001

REGICOR scale high-very high

2.9

5.4

< 0.0001

Fatty liver index high risk

10.7

32.7

< 0.0001

Hepatic steatosis index

59.3

63.1

0.008

Zhejiang University index

52.4

54.4

0.501

Fatty liver disease index

60.6

67.6

0.002